Mainz Biomed B.V. (MYNZ)

USD 3.78

(-14.48%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019
Revenue 895.47 Thousand 529.87 Thousand 577.34 Thousand 493.56 Thousand 281.39 Thousand
Cost of Revenue 385.82 Thousand 347.72 Thousand 399.72 Thousand 370.48 Thousand 342.66 Thousand
Gross Profit 509.65 Thousand 182.15 Thousand 177.62 Thousand 123.08 Thousand -61.27 Thousand
Operating Expenses 27.15 Million 26.35 Million 9.55 Million 479.38 Thousand 690.21 Thousand
Selling, General and Administrative Expenses 17.22 Million 22.81 Million 9.41 Million 458.37 Thousand 570.24 Thousand
Research and Development Expenses 9.59 Million 3.66 Million 466.68 Thousand 311.85 Thousand 250.31 Thousand
Other Expenses 342.4 Thousand -114.04 Thousand -320.89 Thousand -290.83 Thousand -130.34 Thousand
Cost and Expenses 27.54 Million 26.7 Million 9.95 Million 849.86 Thousand 1.03 Million
Operating Income -26.64 Million -26.17 Million -9.37 Million -325.81 Thousand -921.9 Thousand
Interest Expense 809.58 Thousand 289.32 Thousand 339.17 Thousand 268.79 Thousand 201.93 Thousand
Income Tax Expense - 65.38 Thousand 377.12 Thousand 299.28 Thousand 217.71 Thousand
Earnings before Tax -26.29 Million -26.38 Million -11.69 Million -586.89 Thousand -957.05 Thousand
Net Income -26.29 Million -26.45 Million -12.07 Million -886.17 Thousand -1.17 Million
Earnings Per Share Basic -1.62 -1.87 -1.67 -0.16 -0.10
Earnings Per Share Diluted -1.62 -1.87 -1.67 -0.16 -0.10
Weighted Average Shares Outstanding 16.24 Million 14.15 Million 7.21 Million 5.6 Million 11.71 Million
Weighted Average Shares Outstanding (Diluted) 16.24 Million 14.15 Million 7.21 Million 5.6 Million 11.71 Million
Gross Margin 0.57 0.34 0.31 0.25 -0.22
EBIT Margin -27.93 -48.41 -16.05 -0.54 -2.43
Profit Margin -29.36 -49.92 -20.91 -1.80 -4.17
EBITDA -25.01 Million -25.71 Million -11.28 Million -257.64 Thousand -702.07 Thousand
Earnings Before Tax Margin -29.75 -49.40 -16.25 -0.66 -3.28

Income Statement Charts